Abstract
It is now well documented that neoplastic cells are influenced by their microenvironment and viceversa. The specific organ microenvironment determines the extent of cancer cell proliferation, angiogenesis, invasion and survival.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aaltomaa S, Lipponen P, Papinaho S et al (1993) Mast cells in breast cancer. Anticancer Res 13:785–788
Baram D, Vaday G, Salamon P et al (2001) Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 167:4008–4016
Bingle L, Brown NJ, Lewis CE (2002) The role of tumor associated macrophages in tumor progression: implications for new anticancer therapies. J Pathol 196:254–265
Caplan RM (1963) The natural course of urticaria pigmentosa. Arch Dermatol 87:146–157
Chan JK, Magistris A, Loizzi V et al (2005) Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol 99:20–25
Conti P, Pang X, Boucher W et al (1997) Impact of rantes and MCP-1 chemokines on in vivo basohilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mrna levels for histidine decarboxylase. Blood 89:4120–4127
Dabbous M, Walker R, Haney L et al (1986) Mast cells and matrix degradation at sites of tumor invasion in rat mammary adenocarcinoma. Br J Cancer 54:459–465
Dabiri S, Huntsman D, Makretsov N et al (2004) The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol 17:690–695
Dave SS, Wright G, Than B et al (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infilitrating immune cells. N Engl J Med 351:2159–2169
Fukushima N, Satoh T, Sano M et al (2001) Angiogenesis and mast cell in non hodgkin’s lymphoma; a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 42:709–720
Fukushima H, Ohsawa M, Ikura Y et al (2006) Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology 49:498–505
Gooch SJ, Lee AV, Yee D (1998) Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res 58:4199–4205
Gruber BL, Marchese MJ, Kaw R (1995) Angiogenic factors stimulate mast cell migration. Blood 86:2488–2493
Guidolin D, Nico B, Crivellato E et al (2008) Tumoral mast cells exhibit a common spatial distribution. Cancer Lett 273:80–85
Hara M, Matsumori A, Ono K et al (1999) Mast cells cause apotosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 100:1443–1449
He S, Walls AF (1998) Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125:1491–1500
Ho KL (1984) Ultrastructure of cerebellar capillary hemangioblastoma. II. Mast Cells and Angiogenesis. Acta Neuropathol 64:308–318
Iamaroon A, Pongsiriwet S, Jittidecharaks S et al (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 32:195–199
Jenkins DC, Charles IG, Thompson LL et al (1995) Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392–4396
Kankkunen JP, Harvima IT, Naukkarinen A (1997) Qunatitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72:385–388
Leek RD, Lander RJ, Harris AL et al (1999) Necrosis correlates with high vascular density and focal macrophages infiltration in invasive carcinoma of the breast. Br J Cancer 79:991–995
Lennert K, Parwaresch MR (1979) Mast cells and mast cell neoplasia: a review. Histopathology 3:349–365
Liotta L, Kohn EC (2001) The microenvironment of the tumor-host interface. Nature 411:375–379
Maślińska D, Woźniak R, Kaliszek A et al (1999) Phenotype of mast cells in the brain tumor. Capillary Hemangioblastoma. Folia Neuropathol 37:138–142
Molin D (2004) Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis. Ups J Med Sci 109:179–228
Molin D, Edstrom A, Glimelius I et al (2002) Mast cell infilitration correlates with poor prognosis in hodgkin’s lymphoma. Br J Haematol 119:122–124
Nechushtan H, Razin E (2002) The function of MIFT and associated proteins in mast cells. Mol Immunol 38:1177–1180
Nonomura N, Takayama H, Nishimura K et al (2007) Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 97:952–956
Ohno S, Inagawa H, Soma G et al (2002) Role of tumor-associated macrophage in malignant tumors: should the location of the infiltrated macrophages be taken into account during evaluation? Anticancer Res 22:4269–4275
Park CC, Bissell MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6:324–329
Polajeva J, Sjosten AM, Lager N et al (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS ONE 6:e25222
Reszec J, Hermanowicz A, Rutkowski R et al (2013) Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema. J Neurooncol 115:119–125
Rojas IG, Spencer ML, Martinez A et al (2005) Characterization of mast cell subpopulations in lip cancer. J Oral Pathol Med 34:268–273
Samoszuk M, Corwin M (2003) Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int J Cancer 107:159–163
Sharma VK, Agrawal AK, Pratarp VK et al (1992) Mast cell reactivity in lymphoma: a preliminary communication. Indian J Cancer 29:61–65
Stack MS, Johnson DA (1994) Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 269:9416–9419
Theoharides T, Conti P (2004) Mast cells: the jekyll and hyde of tumor growth. Trends Immunol 25:235–241
Theoharides TC, Kempuraj D, Tagen M et al (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217:65–78
Theoharides TC, Rozniecki JJ, Sahagian G et al (2008) Impact of stress and mast cells on brain metastases. J Neuroimmunol 205:1–7
Thoresen S, Tangen M, Hartveit F (1982) Mast cells in the axillary nodes of breast cancer patients. Diagn Histopathol 5:65–67
Torunilhac O, Santos DD, Xu L et al (2006) Mast cells in waldenstrom’s macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol 17:1275–1282
Travis WD, Li CY, Yam LT et al (1988) Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62:965–972
Welsh TJ, Green RH, Richardson D et al (2005) Macrophage and mast cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23:8959–8967
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ribatti, D. (2019). Mast Cells in Tumor Fate. In: The Mast Cell . Springer, Cham. https://doi.org/10.1007/978-3-030-24190-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-24190-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24189-6
Online ISBN: 978-3-030-24190-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)